132 related articles for article (PubMed ID: 25501719)
1. Impact of isoflurane on malignant capability of ovarian cancer in vitro.
Luo X; Zhao H; Hennah L; Ning J; Liu J; Tu H; Ma D
Br J Anaesth; 2015 May; 114(5):831-9. PubMed ID: 25501719
[TBL] [Abstract][Full Text] [Related]
2. Volatile anaesthetics enhance the metastasis related cellular signalling including CXCR2 of ovarian cancer cells.
Iwasaki M; Zhao H; Jaffer T; Unwith S; Benzonana L; Lian Q; Sakamoto A; Ma D
Oncotarget; 2016 May; 7(18):26042-56. PubMed ID: 27028996
[TBL] [Abstract][Full Text] [Related]
3. Isoflurane enhances the malignant potential of glioblastoma stem cells by promoting their viability, mobility in vitro and migratory capacity in vivo.
Zhu M; Li M; Zhou Y; Dangelmajer S; Kahlert UD; Xie R; Xi Q; Shahveranov A; Ye D; Lei T
Br J Anaesth; 2016 Jun; 116(6):870-7. PubMed ID: 27199319
[TBL] [Abstract][Full Text] [Related]
4. Cancerous phenotypes associated with hypoxia-inducible factors are not influenced by the volatile anesthetic isoflurane in renal cell carcinoma.
Sumi C; Matsuo Y; Kusunoki M; Shoji T; Uba T; Iwai T; Bono H; Hirota K
PLoS One; 2019; 14(4):e0215072. PubMed ID: 30986231
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the antiangiogenic effect of Taxol in a human epithelial ovarian carcinoma cell line.
Hata K; Osaki M; Dhar DK; Nakayama K; Fujiwaki R; Ito H; Nagasue N; Miyazaki K
Cancer Chemother Pharmacol; 2004 Jan; 53(1):68-74. PubMed ID: 14569416
[TBL] [Abstract][Full Text] [Related]
6. Sevoflurane promotes the expansion of glioma stem cells through activation of hypoxia-inducible factors in vitro.
Shi QY; Zhang SJ; Liu L; Chen QS; Yu LN; Zhang FJ; Yan M
Br J Anaesth; 2015 May; 114(5):825-30. PubMed ID: 25492570
[TBL] [Abstract][Full Text] [Related]
7. Impact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugs.
Puvanenthiran S; Essapen S; Seddon AM; Modjtahedi H
Int J Oncol; 2016 Nov; 49(5):1825-1838. PubMed ID: 27599579
[TBL] [Abstract][Full Text] [Related]
8. VEGF-D-enhanced lymph node metastasis of ovarian cancer is reversed by vesicular stomatitis virus matrix protein.
Qi X; Du L; Chen X; Chen L; Yi T; Chen X; Wen Y; Wei Y; Zhao X
Int J Oncol; 2016 Jul; 49(1):123-32. PubMed ID: 27211072
[TBL] [Abstract][Full Text] [Related]
9. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
[TBL] [Abstract][Full Text] [Related]
10. Effects of angiogenic growth factor combinations on retinal endothelial cells.
Castellon R; Hamdi HK; Sacerio I; Aoki AM; Kenney MC; Ljubimov AV
Exp Eye Res; 2002 Apr; 74(4):523-35. PubMed ID: 12076096
[TBL] [Abstract][Full Text] [Related]
11. The natural compound codonolactone impairs tumor induced angiogenesis by downregulating BMP signaling in endothelial cells.
Wang S; Cai R; Ma J; Liu T; Ke X; Lu H; Fu J
Phytomedicine; 2015 Oct; 22(11):1017-26. PubMed ID: 26407944
[TBL] [Abstract][Full Text] [Related]
12. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
14. Isoflurane inhibits occludin expression via up-regulation of hypoxia-inducible factor 1α.
Zhao J; Hao J; Fei X; Wang X; Hou Y; Deng C
Brain Res; 2014 May; 1562():1-10. PubMed ID: 24661914
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of small interfering RNA targeting insulin-like growth factor-I receptor in ovarian cancer OVCAR3 cells.
An Y; Cai Y; Guan Y; Cai L; Yang Y; Feng X; Zheng J
Cancer Biother Radiopharm; 2010 Oct; 25(5):545-52. PubMed ID: 20950153
[TBL] [Abstract][Full Text] [Related]
16. NFATc1 regulates cell proliferation, migration, and invasion of ovarian cancer SKOV3 cells in vitro and in vivo.
Li L; Duan Z; Yu J; Dang HX
Oncol Rep; 2016 Aug; 36(2):918-28. PubMed ID: 27350254
[TBL] [Abstract][Full Text] [Related]
17. The insulin-like growth factor 1 receptor induces transformation and tumorigenicity of ovarian mesothelial cells and down-regulates their Fas-receptor expression.
Coppola D; Saunders B; Fu L; Mao W; Nicosia SV
Cancer Res; 1999 Jul; 59(13):3264-70. PubMed ID: 10397275
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
[TBL] [Abstract][Full Text] [Related]
19. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
[TBL] [Abstract][Full Text] [Related]
20. Stem cell-like human endothelial progenitors show enhanced colony-forming capacity after brief sevoflurane exposure: preconditioning of angiogenic cells by volatile anesthetics.
Lucchinetti E; Zeisberger SM; Baruscotti I; Wacker J; Feng J; Zaugg K; Dubey R; Zisch AH; Zaugg M
Anesth Analg; 2009 Oct; 109(4):1117-26. PubMed ID: 19762739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
